Merck KGaA (OTCMKTS:MKKGY) Short Interest Up 84.3% in January

Merck KGaA (OTCMKTS:MKKGY) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 184,605 shares, an increase of 84.3% from the December 31st total of 100,145 shares. Based on an average daily volume of 158,067 shares, the short-interest ratio is presently 1.2 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 158,067 shares, the short-interest ratio is presently 1.2 days.

Merck KGaA Stock Down 1.4%

Shares of OTCMKTS:MKKGY opened at $29.88 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 0.97. The stock has a market cap of $19.31 billion, a price-to-earnings ratio of 11.90, a P/E/G ratio of 6.13 and a beta of 0.95. The company has a 50 day moving average of $28.73 and a 200-day moving average of $26.98. Merck KGaA has a one year low of $24.32 and a one year high of $31.00.

Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earnings data on Thursday, November 13th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.27. The firm had revenue of $6.17 billion for the quarter, compared to analysts’ expectations of $6.08 billion. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. On average, sell-side analysts forecast that Merck KGaA will post 1.87 earnings per share for the current year.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.